Zuzana Kos

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Drug Administration

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Hala Faragalla, Anna Plotkin, Penelope J Barnes, Fang-I Lu, Zuzana Kos, Anna Marie Mulligan, Anita Bane, Sharon Nofech Mozes
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force. Current oncology (Toronto, Ont.) 30 (3) (2023)
Hala Faragalla, Anna Plotkin, Penelope J Barnes, Fang-I Lu, Zuzana Kos, Anna Marie Mulligan, Anita Bane, Sharon Nofech Mozes
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force. Current oncology (Toronto, Ont.) 30 (3) (2023)
Torsten O Nielsen, Samuel C Y Leung, Nazia Riaz, Anna Marie Mulligan, Zuzana Kos, Anita Bane, Timothy J Whelan
Ki67 assessment protocol as an integral biomarker for avoiding radiotherapy in the LUMINA breast cancer trial. Histopathology (2023)
Hala Faragalla, Anna Plotkin, Penelope J Barnes, Fang-I Lu, Zuzana Kos, Anna Marie Mulligan, Anita Bane, Sharon Nofech Mozes
Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force. Current oncology (Toronto, Ont.) 30 (3) (2023)